Alignment Healthcare (ALHC) shares closed Tuesday at $19.20, up 25.1%, after the company presented at Goldman Sachs' global healthcare conference and released updated operating metrics. The stock traded as high as $19.62, with volume exceeding 16 million shares, far outpacing the modest gains of managed-care peers.
The rally marks a significant vote of confidence from investors who have been watching Alignment's efforts to balance rapid membership growth with improved margins. The company's first-quarter results, reported in late April, showed revenue rising 33.3% to $1.24 billion, Medicare Advantage membership increasing 30.9% to approximately 284,800 members, and adjusted EBITDA climbing 87.6% to $37.9 million.
Adjusted EBITDA, a key operating metric that excludes interest, taxes, depreciation, amortization, and certain other costs, underscores Alignment's improving profitability. The company raised the midpoint of its 2026 guidance across membership, revenue, adjusted gross profit, and adjusted EBITDA. For 2026, Alignment now forecasts revenue between $5.16 billion and $5.21 billion, with adjusted EBITDA ranging from $138 million to $163 million.
During the Goldman Sachs presentation, Alignment highlighted its data-driven care model, disciplined expansion strategy, and stable utilization trends as pillars supporting its financial outlook. Utilization, the rate at which members use medical services, has been a critical concern across the Medicare Advantage industry, where tighter government payments and higher care use by seniors have squeezed profits.
Founder and CEO John Kao emphasized the company's disciplined approach in the earnings release: 'Our first-quarter performance demonstrates that Alignment continues to grow with discipline, expanding profitability through sales, clinical operations, and cost management, even as the Medicare Advantage environment continues to change.'
Alignment's stock move stood in stark contrast to the broader managed-care sector. UnitedHealth (UNH) rose about 1.5%, Humana (HUM) gained 1.9%, and Centene (CNC) added 1.8%. The iShares U.S. Healthcare Providers ETF (IHF) advanced roughly 1.9%. Meanwhile, the Nasdaq Composite fell about 1% as technology shares weakened, and the S&P 500 slipped 0.3%, with defensive sectors like healthcare outperforming.
After the close, routine governance filings showed shareholders elected directors Jody Bilney, David Hodgson, and Jacqueline Kosecoff to terms ending at the 2029 annual meeting, ratified Deloitte & Touche as auditor for 2026, and approved executive compensation on an advisory basis.
Despite the positive momentum, risks remain. Alignment has warned that results could be hurt by weaker member growth, delays in entering new markets, lower Medicare Advantage funding, regulatory changes, weaker plan quality ratings, provider-relationship issues, or labor-cost pressure. The sharp stock move also resets expectations, leaving less room for error if medical costs rise or 2026 guidance proves too optimistic.
